Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aptevo Therapeutics (APVO) Non-cash Items (2016 - 2025)

Aptevo Therapeutics' Non-cash Items history spans 10 years, with the latest figure at $1.0 for Q3 2025.

  • For Q3 2025, Non-cash Items fell 100.0% year-over-year to $1.0; the TTM value through Sep 2025 reached $1.0, down 100.0%, while the annual FY2024 figure was $100000.0, 59.73% down from the prior year.
  • Non-cash Items for Q3 2025 was $1.0 at Aptevo Therapeutics, down from $40000.0 in the prior quarter.
  • Across five years, Non-cash Items topped out at $43.2 million in Q4 2021 and bottomed at $1.0 in Q3 2025.
  • The 5-year median for Non-cash Items is $187838.0 (2022), against an average of $3.0 million.
  • The largest annual shift saw Non-cash Items surged 2807.82% in 2022 before it crashed 100.0% in 2025.
  • A 5-year view of Non-cash Items shows it stood at $43.2 million in 2021, then crashed by 99.57% to $187838.0 in 2022, then soared by 32.21% to $248346.0 in 2023, then tumbled by 59.73% to $100000.0 in 2024, then crashed by 100.0% to $1.0 in 2025.
  • Per Business Quant, the three most recent readings for APVO's Non-cash Items are $1.0 (Q3 2025), $40000.0 (Q2 2025), and $311.0 (Q1 2025).